目的:本研究的主要目的是分离,identify,并使用一些常见的病原微生物以及毒理学谱定量B.dalzielii的粗水性茎皮提取物中存在的活性抗菌化合物。
方法:乳香(CASEB)的粗水性树皮提取物通过制备薄层色谱法(PTLC)使用氯仿-甲醇-水进行分配,8:2:1(v/v)。使用氯仿-甲醇(50:50)提取所得条带。评估每个条带的提取物对化脓性链球菌的抗菌活性,金黄色葡萄球菌,大肠杆菌,粪肠球菌,肺炎克雷伯菌,铜绿假单胞菌,变形杆菌,伤寒沙门氏菌,和白色念珠菌通过椎间盘扩散。通过高效液相色谱(HPLC)鉴定了最具抗菌生物活性部分(MAAF)中的化合物,傅里叶变换红外分光光度法(FT-IR),和气相色谱-质谱(GC-MS)。通过研究CASEB在白化病Wister大鼠中的作用来评估CASEB的毒理学特征。
结果:PTLC产生5条条带/级分,其中MAAF被鉴定为对除大肠杆菌和肺炎克雷伯菌以外的所有分离株具有活性的RF2级分。MAAF的HPLC显示7个组分;FT-IR显示17个官能团;GC-MS显示5个化合物,其中93.18%为油酸(44.88%),角鲨烯(34.16%),和正十六烷酸(14.14%)。急性毒性显示LD50>3,000mg/kg。亚慢性毒性表明,较高剂量的CASEB引起肝功能指标的显着变化和肝脏组织中淋巴细胞浸润的脂肪变化(急性肝炎的迹象),但是在肾脏中没有观察到这些变化。
结论:CASEB中的抗菌活性化合物是油酸,角鲨烯,和正十六烷酸。这些可以进一步纯化并用作新的抗微生物剂的前体,用于治疗感染,尤其是真菌和假单胞菌属的感染。已知能抵抗广泛的抗微生物剂。大鼠中CASEB的LD50>3,000mg/kg。然而,长期服用CASEB与显著的肝损伤相关.
OBJECTIVE: The main objective of this study is to isolate, identify, and quantify the active antimicrobial compounds present in the crude aqueous stem bark extract of B. dalzielii using some common pathogenic microorganisms as well as toxicological profile.
METHODS: Crude aqueous stem bark extract of Boswellia dalzielii (CASEB) was partitioned by preparative thin layer chromatography (PTLC) using chloroform-methanol-water, 8:2:1 (v/v). The resulting bands were extracted using chloroform-methanol (50:50). The extract of each band was evaluated for antimicrobial activity on Streptococcus pyogenes, Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Klebsiella pneumonia, Pseudomonas aeruginosa, Proteus mirabilis, Salmonella typhi, and Candida albicans by disc diffusion. Compounds in the most antimicrobially bioactive fraction (MAAF) were identified by high performance liquid chromatography (HPLC), Fourier transform infrared spectrophotometry (FT-IR), and gas chromatography-mass spectrometry (GC-MS). Toxicological profile of the CASEB was evaluated by studying its effect in albino Wister rats.
RESULTS: PTLC produced five bands/fractions of which the MAAF was identified as RF2-fraction being active against all the isolates except E. coli and K. pneumoniae. HPLC of the MAAF revealed seven components; FT-IR revealed 17 functional groups; GC-MS revealed five compounds of which 93.18% are Oleic acid (44.88%), Squalene (34.16%), and n-Hexadecanoic acid (14.14%). The acute toxicity showed LD50 > 3,000 mg/kg. Sub-chronic toxicity showed that higher doses of the CASEB caused significant changes in liver function indices and a fatty change with lymphocytic infiltration (sign of acute hepatitis) in the liver tissues, but none of these changes were observed in the kidneys.
CONCLUSIONS: The antimicrobially active compounds in CASEB were Oleic acid, Squalene, and n-Hexadecanoic acid. These can be further purified and used as precursors of new antimicrobial agents for treating infections especially those due to fungi and Pseudomonas spp. that are known to resist wide array of antimicrobial agents. The LD50 of CASEB is >3,000 mg/kg in rats. However, long-term consumption of CASEB is associated with significant liver damage.